BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18583174)

  • 1. Alpha-synuclein and autophagy as common steps in neurodegeneration.
    Ferrucci M; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S180-4. PubMed ID: 18583174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
    Pan T; Kondo S; Le W; Jankovic J
    Brain; 2008 Aug; 131(Pt 8):1969-78. PubMed ID: 18187492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein.
    Yang F; Yang YP; Mao CJ; Cao BY; Cai ZL; Shi JJ; Huang JZ; Zhang P; Liu CF
    Neurosci Lett; 2009 May; 454(3):203-8. PubMed ID: 19429084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of alpha-synuclein following methamphetamine: is it good or bad?
    Mauceli G; Busceti CI; Pellegrini A; Soldani P; Lenzi P; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2006 Aug; 1074():191-7. PubMed ID: 17105917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
    Li B; Zhang Y; Yuan Y; Chen N
    Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp70 molecular chaperones and Parkinson's disease.
    Witt SN
    Biopolymers; 2010 Mar; 93(3):218-28. PubMed ID: 19768775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein.
    Lee HJ; Khoshaghideh F; Lee S; Lee SJ
    Eur J Neurosci; 2006 Dec; 24(11):3153-62. PubMed ID: 17156376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does autophagy worsen or improve the survival of dopaminergic neurons?
    Pasquali L; Ruggieri S; Murri L; Paparelli A; Fornai F
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S24-7. PubMed ID: 20123552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of alpha-synuclein in both neuroprotection and neurodegeneration.
    Sidhu A; Wersinger C; Moussa CE; Vernier P
    Ann N Y Acad Sci; 2004 Dec; 1035():250-70. PubMed ID: 15681812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine.
    Castino R; Lazzeri G; Lenzi P; Bellio N; Follo C; Ferrucci M; Fornai F; Isidoro C
    J Neurochem; 2008 Aug; 106(3):1426-39. PubMed ID: 18489716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain-resistant fragment(s) of alpha-synuclein regulates the synuclein-cleaving activity of 20S proteasome.
    Kim HJ; Lee D; Lee CH; Chung KC; Kim J; Paik SR
    Arch Biochem Biophys; 2006 Nov; 455(1):40-7. PubMed ID: 17005155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of autophagy during methamphetamine neurotoxicity.
    Pasquali L; Lazzeri G; Isidoro C; Ruggieri S; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2008 Oct; 1139():191-6. PubMed ID: 18991864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.
    Gerlach M; Riederer P; Double KL
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S185-8. PubMed ID: 18585086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
    Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
    Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC6 regulates aggresome-autophagy degradation pathway of α-synuclein in response to MPP+-induced stress.
    Su M; Shi JJ; Yang YP; Li J; Zhang YL; Chen J; Hu LF; Liu CF
    J Neurochem; 2011 Apr; 117(1):112-20. PubMed ID: 21235576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.